Remission | Active | P value | |
---|---|---|---|
Number of patients | 9 | 5 | |
Gender | |||
Male | 3 | 2 | 0.969 |
Female | 6 | 3 | |
Mean age (±SD), yr | 28.8 ± 16.8 | 24.0 ± 8.7 | 0.898 |
BMI (±SD), kg/m2 | 18.6 ± 3.1 | 20.2 ± 6.3 | 0.898 |
CDAI | |||
≥ 150 | 5 | 4 | 0.658 |
< 150 | 4 | 1 | |
Disease location | |||
Ileal type | 3 | 0 | 0.167 |
Ileocolonic type | 6 | 4 | |
Colonic type | 0 | 1 | |
Induction therapy a | |||
5-ASA | 6 | 3 | |
Steroid | 1 | 0 | |
Azathioprine | 2 | 0 | |
Infliximab | 8 | 5 | |
Adalimumab | 1 | 0 | |
GMA/LCAP | 0 | 0 | |
AIM (μg/ml) | |||
Before treatment | |||
Average (±SD) | 3.8 ± 3.7 | 3.3 ± 2.1 | 0.797 |
After treatment | |||
Average (±SD) | 4.4 ± 5.3 | 3.1 ± 2.7 | 0.699 |